Effective August 2, 2022, mdxhealth has acquired the Oncotype DX GPS (Genomic Prostate Score) test from Exact Sciences. To help ensure a smooth transition for patients, continue to place orders for this test through the existing Exact Sciences portal until further notice. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the Oncotype DX GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the following press release. Questions? Email: gps@mdxhealth.com

PUBLICATIONS & ABSTRACTS

Rigorous science. Revolutionary solutions.

At Exact Sciences, we are committed to helping patients stay ahead of cancer. Our teams use their scientific expertise to practice innovation driven by robust research and cutting-edge science. We practice thorough, sound research that helps patients face challenging decisions with confidence.

Highlighted publications

September 2022

Multi-cancer early detection through evaluation of aneuploidy, methylation, mutation, and protein biomarkers in plasma

View »

Cancer Prevention Research

January 2021

Specificity of the multi-target stool DNA test for colorectal cancer screening in average-risk 45-49 year-olds: a cross-sectional study

View »

Current Medical Research and Opinion

January 2021

Recent trends in colorectal cancer screening methods based on Medicare claims data

View »

PLoS One

December 2020

Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model

View »

Clinical Gastroenterology and Hepatology

July 2019

Low incidence of aerodigestive cancers in patients with negative results from colonoscopies, regardless of findings from multi-target stool DNA tests.

View »

Journal of Medical Screening

January 2020

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: real-world data from a large cohort of older adults

View »

Clinical Gastroenterology and Hepatology

August 2020

A Novel Blood-based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma

View »